Marathon Patent Group's Wholly-Owned Subsidiary MedTech Development Deutschland GmbH Receives Favorable Preliminary Ruling of Infringement Against Joline GmbH & Co. KG, Signus Medizintechnik GmbH and PanMedical
(firmenpresse) - LOS ANGELES, CA -- (Marketwired) -- 07/02/15 -- (NASDAQ: MARA) ("Marathon"), a patent licensing company, announced that on July 1, 2015, in the patent infringement action filed by its wholly-owned subsidiary, MedTech Development Deutschland GmbH involving the patent EP 1 104 260 B2 (the '260 patent) the Munich District Court of Germany expressed in its preliminary opinion that the following defendants, Joline GmbH & Co. KG, Signus Medizintechnik GmbH and PanMedical, infringe the '260 patent.
The '260 patent had previously been accused of invalidity by Stryker GmbH & Co. KG ("Stryker Germany"). In a nullity hearing held June 19, 2015, the five-judge panel at the Federal Patent Court, after carefully considering all facts and arguments brought by Stryker, deliberated and returned with the unrestricted verdict that "All claims are valid."
"We are pleased that the Munich District Court has expressed its preliminary opinion that the defendants infringe the '260 patent. Today's court hearing, and the continuing injunction against Stryker, have the potential of creating further incentive for the parties in dispute to explore and discuss mutual resolution in the form of an equitable licensing agreement, much like the one just executed with Maxxspine Limited, which involves a lump sum royalty payment for products already sold, as well as a running royalty rate for future sales," said Doug Croxall, CEO of Marathon Patent Group.
Marathon is a patent acquisition and monetization company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. Marathon's strategy of acquiring patents that cover a wide-range of subject matter allows the Company to achieve diversity within its patent asset portfolio. Marathon generates revenue with its diversified portfolio through actively managed concurrent patent rights enforcement campaigns. This approach is expected to result in a long-term, diversified revenue stream. To learn more about Marathon Patent Group, visit .
attorney-of-record of MedTech Development Deutschland GmbH
Noerr is one of the top European law firms with more than 500 professionals in Germany, Europe and the USA. The firm delivers real value to clients by devising and handling the right solutions to complex and sophisticated legal matters. The Noerr difference is its unique combination of legal excellence, creative thinking, international experience and in-depth industry knowledge.
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
Marathon Patent Group
Jason Assad
678-570-6791
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.07.2015 - 14:05 Uhr
Sprache: Deutsch
News-ID 404501
Anzahl Zeichen: 0
contact information:
Town:
LOS ANGELES, CA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 267 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Marathon Patent Group's Wholly-Owned Subsidiary MedTech Development Deutschland GmbH Receives Favorable Preliminary Ruling of Infringement Against Joline GmbH & Co. KG, Signus Medizintechnik GmbH and PanMedical"
steht unter der journalistisch-redaktionellen Verantwortung von
Marathon Patent Group (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
